CooperCompanies has acquired certain medical device assets, focused primarily on Doppler monitoring, obstetrics and gynaecology surgery markets, from Cook Medical for approximately $300m.
As part of the deal, CooperCompanies made a $200m payment at the closing of the transaction.
Go deeper with GlobalData
The company will make the remaining payment of $100m in two annual instalments.
The assets that are being acquired by the company are primarily minimally invasive medical devices.
They include a large portion of Cook’s Maternal Fetal Medicine products, gynaecological surgery products and the Doppler monitor technology, disposable devices and accessories.
Cook Medical plans to continue to manufacture these products for at least two years.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataDuring this period, Cook will transfer the manufacturing to CooperSurgical.
As of 30 September 2023, the acquired assets generated a trailing 12-month revenue of $56m.
Starting in its fiscal first quarter of 2024, Cooper plans to report the acquired assets as part of its Office and Surgical category within the CooperSurgical business.
The deal comes months after CooperCompanies abandoned plans to acquire Cook Medical’s reproductive health business in an $875m transaction, following an investigation by the US Federal Trade Commission.
The latest transaction excludes any of the fertility products contemplated in the original deal.
CooperCompanies CEO and president Al White said: “The acquired products are highly synergistic with CooperSurgical’s existing portfolio of medical devices and strengthen CooperSurgical’s position as a leading global fertility and women’s health company.”
Cook Medical and Cook Group president Pete Yonkman said: “This agreement will allow us to invest in future growth and new technologies while also allowing the new Cooper product lines to thrive and meet patients’ needs around the world. The rest of the Cook organisation will continue as privately held, family-owned companies.”
